Skip to Content

HAW 513 (Utira-C 0.12 mg / 81.6 mg / 10.8 mg / 36.2 mg)

Pill with imprint HAW 513 is Purple, Elliptical / Oval and has been identified as Utira-C 0.12 mg / 81.6 mg / 10.8 mg / 36.2 mg. It is supplied by Hawthorn Pharmaceuticals.

Hyoscyamine/methenamine/methylene blue/phenyl salicylate is used in the treatment of urinary tract infection and belongs to the drug class urinary antispasmodics. Risk cannot be ruled out during pregnancy. Hyoscyamine/methenamine/methylene blue/phenyl salicylate 0.12 mg / 81.6 mg / 10.8 mg / 36.2 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for HAW 513

Utira-C 0.12 mg / 81.6 mg / 10.8 mg / 36.2 mg HAW 513

Utira-C

Imprint
HAW 513
Strength
0.12 mg / 81.6 mg / 10.8 mg / 36.2 mg
Color
Purple
Size
435.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Urinary antispasmodics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Hawthorn Pharmaceuticals
National Drug Code (NDC)
63717-0513

Get help with Imprint Code FAQs.

Related Images for "HAW 513"

More about hyoscyamine / methenamine / methylene blue / phenyl salicylate

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.